BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez-Rey E, Martínez-Romero R, O'Valle F, Aguilar-Quesada R, Conde C, Delgado M, Oliver FJ. Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response. PLoS One 2007;2:e1071. [PMID: 17971849 DOI: 10.1371/journal.pone.0001071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Jing Y, Jia M, Zhang L. Negative transcriptional regulation of inflammatory genes by group B3 vitamin nicotinamide. Mol Biol Rep 2012;39:10367-71. [DOI: 10.1007/s11033-012-1915-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Nossa CW, Blanke SR. Helicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular health. Gut Microbes 2010;1:373-8. [PMID: 21468218 DOI: 10.4161/gmic.1.6.13572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 García S, Mera A, Gómez-Reino JJ, Conde C. Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis. Rheumatology (Oxford) 2009;48:483-9. [PMID: 19228791 DOI: 10.1093/rheumatology/ken502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
4 Adachi K, Miyajima SI, Nakamura N, Miyabe M, Kobayashi Y, Nishikawa T, Suzuki Y, Kikuchi T, Kobayashi S, Saiki T, Mizutani M, Ohno N, Noguchi T, Mitani A, Matsubara T, Naruse K. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes. J Clin Periodontol 2017;44:971-80. [PMID: 28570002 DOI: 10.1111/jcpe.12758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Makogon N, Voznesenskaya T, Bryzgina T, Sukhina V, Grushka N, Alexeyeva I. Poly(ADP-ribose) polymerase inhibitor, 3-aminobenzamide, protects against experimental immune ovarian failure in mice. Reprod Biol 2010;10:215-26. [PMID: 21113202 DOI: 10.1016/s1642-431x(12)60041-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Nasta F, Laudisi F, Sambucci M, Rosado MM, Pioli C. Increased Foxp3+ regulatory T cells in poly(ADP-Ribose) polymerase-1 deficiency. J Immunol 2010;184:3470-7. [PMID: 20208002 DOI: 10.4049/jimmunol.0901568] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
7 Jubin T, Kadam A, Gani AR, Singh M, Dwivedi M, Begum R. Poly ADP-ribose polymerase-1: Beyond transcription and towards differentiation. Semin Cell Dev Biol 2017;63:167-79. [PMID: 27476447 DOI: 10.1016/j.semcdb.2016.07.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
8 Wang X, Parapanov R, Debonneville A, Wang Y, Abdelnour‐berchtold E, Gonzalez M, Gronchi F, Perentes J, Ris H, Eckert P, Piquilloud L, Lugrin J, Letovanec I, Krueger T, Liaudet L. Treatment with 3‐aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation. Am J Transplant 2020;20:967-76. [DOI: 10.1111/ajt.15695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rosado MM, Bennici E, Novelli F, Pioli C. Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology 2013;139:428-37. [PMID: 23489378 DOI: 10.1111/imm.12099] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 11.6] [Reference Citation Analysis]
10 Wenke AK, Bosserhoff AK. Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development. FEBS J 2010;277:894-902. [PMID: 20050923 DOI: 10.1111/j.1742-4658.2009.07509.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
11 Li G, Cunin P, Wu D, Diogo D, Yang Y, Okada Y, Plenge RM, Nigrovic PA. The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1. PLoS Genet 2016;12:e1006292. [PMID: 27626929 DOI: 10.1371/journal.pgen.1006292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
12 Koc A, Aydin Sayitoglu M, Karakurt F, Batar B, Niyazoglu M, Celik O, Onaran I, Tasan E, Sultuybek GK. Association of three SNPs in the PARP-1 gene with Hashimoto's thyroiditis. Hum Genome Var 2014;1:14016. [PMID: 27081507 DOI: 10.1038/hgv.2014.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 O'Valle F, Peregrina M, Crespo-Lora V, Galindo-Moreno P, Roman M, Padial-Molina M, Mesa F, Aneiros-Fernandez J, Aguilar D, Gonzalez-Rey E, Delgado M, Hernandez-Cortes P. Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis. Biomed Res Int 2015;2015:681456. [PMID: 26064941 DOI: 10.1155/2015/681456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Peralta-Leal A, Rodríguez-Vargas JM, Aguilar-Quesada R, Rodríguez MI, Linares JL, de Almodóvar MR, Oliver FJ. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radic Biol Med 2009;47:13-26. [PMID: 19362586 DOI: 10.1016/j.freeradbiomed.2009.04.008] [Cited by in Crossref: 128] [Cited by in F6Publishing: 130] [Article Influence: 9.8] [Reference Citation Analysis]
15 Jog NR, Caricchio R. The role of necrotic cell death in the pathogenesis of immune mediated nephropathies. Clin Immunol 2014;153:243-53. [PMID: 24845790 DOI: 10.1016/j.clim.2014.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
16 García S, Conde C. The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid Arthritis. Mediators Inflamm 2015;2015:837250. [PMID: 26339143 DOI: 10.1155/2015/837250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
17 Ahmad A, Olah G, Herndon DN, Szabo C. The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury. Br J Pharmacol 2018;175:232-45. [PMID: 28146604 DOI: 10.1111/bph.13735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
18 Mehrotra P, Krishnamurthy P, Sun J, Goenka S, Kaplan MH. Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development. Immunology 2015;146:537-46. [PMID: 26222149 DOI: 10.1111/imm.12515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
19 Giansanti V, Donà F, Tillhon M, Scovassi AI. PARP inhibitors: new tools to protect from inflammation. Biochem Pharmacol 2010;80:1869-77. [PMID: 20417190 DOI: 10.1016/j.bcp.2010.04.022] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
20 Alhosaini K, Ansari MA, Nadeem A, Bakheet SA, Attia SM, Alhazzani K, Albekairi TH, Al-Mazroua HA, Mahmood HM, Ahmad SF. 5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism. Brain Sci 2021;11:249. [PMID: 33671196 DOI: 10.3390/brainsci11020249] [Reference Citation Analysis]
21 Yélamos J, Moreno-Lama L, Jimeno J, Ali SO. Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies. Cancers (Basel) 2020;12:E392. [PMID: 32046278 DOI: 10.3390/cancers12020392] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
22 Jog NR, Dinnall JA, Gallucci S, Madaio MP, Caricchio R. Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J Immunol 2009;182:7297-306. [PMID: 19454727 DOI: 10.4049/jimmunol.0803565] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
23 Ahmad SF, Zoheir KM, Ansari MA, Korashy HM, Bakheet SA, Ashour AE, Al-Shabanah OA, Al-harbi MM, Attia SM. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Mol Immunol 2015;63:394-405. [PMID: 25304310 DOI: 10.1016/j.molimm.2014.09.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ahmad SF, Zoheir KM, Bakheet SA, Ashour AE, Attia SM. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model. Cytokine 2014;68:76-85. [PMID: 24845796 DOI: 10.1016/j.cyto.2014.04.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
25 Martínez-Morcillo FJ, Cantón-Sandoval J, Martínez-Menchón T, Corbalán-Vélez R, Mesa-Del-Castillo P, Pérez-Oliva AB, García-Moreno D, Mulero V. Non-canonical roles of NAMPT and PARP in inflammation. Dev Comp Immunol 2021;115:103881. [PMID: 33038343 DOI: 10.1016/j.dci.2020.103881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Cho SH, Raybuck A, Wei M, Erickson J, Nam KT, Cox RG, Trochtenberg A, Thomas JW, Williams J, Boothby M. B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase. J Immunol 2013;191:3169-78. [PMID: 23956424 DOI: 10.4049/jimmunol.1301106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
27 Kunze FA, Hottiger MO. Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond. Trends Immunol 2019;40:159-73. [PMID: 30658897 DOI: 10.1016/j.it.2018.12.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
28 Grushka NG. [THE EFFECT OF OF POLY(ADP-RIBOSE) POLYMERASE INHIBITOR 4-HYDROXY-QUINAZOLINE ON DEATH OF IMMUNE CELLS UNDER IMMUNE COMPLEX-MEDIATED INJURY IN MICE]. Fiziol Zh 2017;63:43-50. [PMID: 29975827 DOI: 10.15407/fz63.01.043] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Selvaraj V, Soundarapandian MM, Chechneva O, Williams AJ, Sidorov MK, Soulika AM, Pleasure DE, Deng W. PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis. J Biol Chem 2009;284:26070-84. [PMID: 19628872 DOI: 10.1074/jbc.M109.013474] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
30 Lee EK, Konstantinopoulos PA. PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers. Ther Adv Med Oncol 2020;12:1758835920944116. [PMID: 32782491 DOI: 10.1177/1758835920944116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alqahtani F, Alhoshani AR, Alasmari F, Alsaleh NB, Attia SM. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T+ Itpr3tf/J mouse model for autism. Pharmacol Biochem Behav 2020;189:172859. [PMID: 31982447 DOI: 10.1016/j.pbb.2020.172859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lengyel-Zhand Z, Puentes LN, Mach RH. PARkinson's: From cellular mechanisms to potential therapeutics. Pharmacol Ther 2021;:107968. [PMID: 34391789 DOI: 10.1016/j.pharmthera.2021.107968] [Reference Citation Analysis]